$MRK.TSX Q3 '26 Earnings Results & Recap Merck & Co. narrowed and raised the midpoint of full-year 2026 sales guidance to $66.8B-$67.3B and non-GAAP EPS guidance to $2.77-$2.82, including a $0.12 per-share SciBrunch charge.
$MRK.TSX Q3 '26 Earnings Results & Recap Merck & Co. narrowed and raised the midpoint of full-year 2026 sales guidance to $66.8B-$67.3B and non-GAAP EPS guidance to $2.77-$2.82, including a $0.12 per-share SciBrunch charge.